Product Description: KIN-8194 is an orally active dual inhibitor of HCK and BTK, with IC50 values of 0.915 and [1][2].
Applications: Cancer-Kinase/protease
Formula: C28H33N7O
References: [1]Lantermans HC, et al. The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. Leukemia. 2024 Mar 7. /[2]Yang G, et al. The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance. Blood. 2021 Nov 18;138(20):1966-1979.